Oncotarget

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 12/15/2017.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Risk of hematologic toxicities and peripheral neuropathy with nab-paclitaxel in treatment of malignancy: an up-to-date metaanalysis

Yihua Liu, Yihua Liu, Huiting Fan, Huiting Fan, Ying Zhang, Ying Zhang, Yong Yang, Yong Yang, Hongsheng Lin _ and Hongsheng Lin _

 

Yihua Liu1,2, Huiting Fan1, Ying Zhang1, Yong Yang3 and Hongsheng Lin1

1 Department of Oncology, Guang’anmen Hospital, Affiliated to China Academy of Chinese Medical Sciences, Beijing, 100053, China

2 Beijing University of Chinese Medicine, Beijing, 100029, China

3 Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Beijing, 100010, China

Correspondence to:

Hongsheng Lin, email: [email protected]

Keywords: nab-paclitaxel; taxanes; peripheral neuropathy; hematological toxicities; meta-analysis

Received: August 19, 2017    Accepted: November 13, 2017    Epub: December 15, 2017    


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23287